RxDoctor Payments Data

Kendra Watts

Family · Sylvania, OHNPI 1689927667

Payments from drug & device makers

$3,774in general payments, 2019–2025

Across 208 payments — averaging $18.14 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$585
  • Novo Nordisk$445
  • Otsuka America Pharmaceutical, Inc.$397
  • AbbVie$388
  • Axsome Therapeutics, Inc.$291
  • Lilly USA, LLC$257
  • plus $1K from 15 others

What the payments were for

  • Food & beverage$3,774100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$3,774 in reported general payments places this provider in the 90th percentile of 6,812 family providers in Ohio.

See all family providers in Ohio

Medicare billing

Part B allowed, 2024
$27,427
Medicare patients
146
Services billed
410

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide24$25,448
JardianceEmpagliflozin29$23,278
TrulicityDulaglutide19$21,277
WegovySemaglutide11$14,896
FarxigaDapagliflozin Propanediol14$11,090
Trelegy ElliptaFluticasone/Umeclidin/Vilanter13$9,376
Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog15$8,174
Rosuvastatin Calcium62$1,669
Atorvastatin Calcium167$1,420
Levothyroxine Sodium109$1,214
Pantoprazole Sodium80$1,004
Metoprolol Succinate74$973
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen31$816
Lisinopril109$570
Omeprazole63$550

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic, Wegovy$445$40,34435 claims
Boehringer IngelheimJardiance$196$23,27829 claims
Lilly USA, LLCTrulicity$257$21,27719 claims
AstraZenecaFarxiga$585$11,09014 claims
GSKTrelegy Ellipta$105$9,37613 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 6,812 family providers in Ohio.

Other family in Sylvania

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →